Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
NRG Oncology
Royal Marsden NHS Foundation Trust
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
University of Chicago
Sanford Health
Providence Health & Services
University of Pittsburgh
Abramson Cancer Center at Penn Medicine
University of Oxford
Case Comprehensive Cancer Center
Cairo University
University College, London
The Netherlands Cancer Institute
Baptist Health South Florida
H. Lee Moffitt Cancer Center and Research Institute
Southern Tohoku BNCT Research Center
University of Kansas Medical Center
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Zurich
Northwell Health
Ottawa Hospital Research Institute
Vanderbilt-Ingram Cancer Center
Georgetown University
Centre Hospitalier Universitaire de Nīmes
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
The University of Texas Medical Branch, Galveston
University of Pittsburgh
British Columbia Cancer Agency
University Health Network, Toronto
Memorial Sloan Kettering Cancer Center
Icahn School of Medicine at Mount Sinai
University Hospital, Ghent
University of Arkansas
Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stanford University
University College, London
M.D. Anderson Cancer Center
National Baromedical Services
Herlev Hospital
Stanford University